Shipped cold to your door  ·  Lyophilized vialsQuestions? WhatsApp +62 811 2120 5090
A cyclist riding along an open road
Wellness

Mitochondrial peptides: getting to know MOTS-c and SS-31

7 August 2026

Mitochondrial health is an increasingly popular topic, especially among people interested in cellular energy and healthy aging. Mitochondria are the right starting point for understanding that conversation, because that is where the cell handles its energy production.

Two names that often come up in it are MOTS-c and SS-31. Both are linked to mitochondria, but they work from different points. Understanding the difference makes the research information about both easier to follow.

The part of the cell that handles energy

Mitochondria are organelles inside the cell that handle energy production. These organelles have their own genetic material, separate from the cell nucleus. This detail matters because it is what sets the origin of MOTS-c apart from compounds designed to interact with mitochondrial structures.

Inside the mitochondria there is an inner membrane, the structural part where energy production takes place. This cell-level explanation is useful as a starting map for understanding the two peptides.

MOTS-c, a peptide that comes from mitochondria

MOTS-c is a short peptide whose sequence is encoded in the genetic material of the mitochondria. This means it does originate from the organelle itself. The research most often discussed looks at it in relation to the regulation of energy metabolism and how the body uses glucose.

Laboratory research has largely observed MOTS-c in skeletal muscle. Research in humans continues to develop, which makes MOTS-c one of the most interesting names to follow in this field.

SS-31, an approach from the mitochondrial membrane

SS-31 is discussed from a different direction. This compound attaches to the inner mitochondrial membrane, the structural part where energy production takes place. For that reason, the discussion sits at the cell level, not at the hormone level.

Oxidative stress often appears as context in discussions of SS-31. For separate context on that topic, read Getting to know glutathione and its role in the body. In the United States, SS-31 under the name elamipretide was approved by the FDA in September 2025 specifically for Barth syndrome, a rare mitochondrial disorder. For other contexts, research on it is ongoing.

NAD+ is also in the catalog as another line of discussion at the cell level. All three sit within the same theme, and each has its own way of working.

Reading the product information

MOTS-c and SS-31 are substances currently being studied, and the information about both comes from research. Each person responds differently. Read A guide to reading peptide product information for guidance on reading peptide product information.

In the Peptivia catalog, MOTS-c is in the Metabolism and fat burning group, while SS-31 is in the Anti-aging and antioxidants group. The vial size for each is listed on the relevant product page.

Details for each product are available in the catalog and the full product list. You can send questions about the products through Peptivia's official WhatsApp.

Peptides in this article

Still deciding which one fits? Tell us your goal and we will help you narrow it down.

Chat on WhatsApp